Akin Akinc
Login to view DISC.Akin Akinc is the CEO of Aera Therapeutics, a company developing next-generation genetic medicines. He has a deep background in RNAi therapeutics from his nearly two decades at Alnylam Pharmaceuticals, where he held leadership roles including SVP and Head of Oncology. He earned his PhD in Chemical Engineering from MIT and a BSE from Princeton University.
He has a strong interest in building effective teams and believes that a combination of good science and a great team is the key to creating successful products. Akin frequently expresses gratitude for mentorship and collaboration opportunities within the biotech community.
His research at Alnylam on lipid nanoparticles was instrumental in the development of Onpattro®, the worlds first approved RNAi therapeutic.
Read the full overview →How Akin shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Akin cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.